Dana-Farber ends 2017 with $36.8M operating loss

Boston-based Dana-Farber Cancer Institute ended 2017 with an operating loss of $36.8 million, compared to operating income of $29.7 million in the year prior.

Dana-Farber saw revenues increase 8.4 percent year over year to $1.52 billion in 2017, according to recently released bondholder documents. The hospital's patient service revenue and research revenue grew 6 percent and 12.3 percent, respectively, year over year.

Higher expenses offset the hospital's revenue gains. In 2017, Dana-Farber recorded operating expenses of $1.56 billion. That's up from $1.38 billion in the year prior.

After factoring in strong investment gains, Dana-Farber ended 2017 with net income of $21.2 million, compared to $36.8 million in 2016.

More articles on healthcare finance:

Miami hospital files for bankruptcy: 4 things to know
Moody's: Nursing shortage will pressure hospital margins for years
Wisconsin hospital at risk of losing Medicare contract over injuries to babies

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Top 40 Articles from the Past 6 Months